News & Insights
Besides sharing our hands-on expertise in projects, we regularly share industry insights, updates, and news.
Webinar LV Process for CAR T
Shifting from traditional, ad hoc methodologies to a structured, data-based development approach to create a scalable, GMP-ready process.
Webinar CAR Therapy Today & Tomorrow
Explore available CAR therapies, differentiation, development challenges, and lessons learned from our expert scientist.
Webinar Product Quality For Cell Therapies
This session is all about building and testing strategies to set the groundwork for effective development and testing in your own work.
Webinar iPSC Banking & Derivation
iPSC Banking & Derivation Ever wondered how to transition from bench to GMP suitable processes in the iPSC-derived therapies field? Yes? Watch the webinar replay on iPSC Derivation & Banking.Key areas of focus include: Transitioning from Bench to GMP Suitable...
iPSC Reprogramming & Transdifferentiation
iPSC reprogramming and cell transdifferentiation offer exciting cellular science opportunities. Learn how these approaches are changing regenerative medicine and cellular therapy.
Differentiation of Human iPSCs
Human induced pluripotent stem cells (iPSCs) offer great potential for the future of medicine. We look into the world of human iPSCs, exploring their incredible promise and the critical significance of directing their development towards specialised cell lineages.
iPSC Development: Technical, Clinical, and Regulatory Hurdles
Induced pluripotent stem cells hold immense promise in revolutionising medicine through patient-specific therapies. However, their clinical development presents intricate challenges, including safety validation, differentiation complexities, and ethical considerations.
Exploring the Impact of iPSC-Derived Organoids on Biomedical Science
Discover the role of iPSC-derived organoids in biomedical science, advancing our understanding of human biology and opening doors.
The Ethical Advantages of iPSCs
Stem cell research has long been mired in ethical controversies, primarily around embryonic stem cell use, which involves complex moral and philosophical debates. The advent of iPSCs presents a turning point, promising a less contentious path forward in regenerative medicine.
IPSCs, what are they? And what is their potential?
What are iPSCs? And how can we harness induced Pluripotent Stem Cells’ potential for the betterment of patient care?
Cell and Gene Therapy companies in Europe
European Cell & Gene Therapy CompaniesAt NecstGen, we aim to support industry partnerships and growth. And to enable the next generation of therapies, it is pivotal to have oversight of the gene and therapy landscape to start from, which is why we created this...
Outsourcing Cell Therapy Manufacturing
Here are the questions you want to ask yourself when considering the outsourcing Cell Therapy Manufacturing to a CDMO. Do you have additional questions? Let us know!
The First Stages of CAR T Cell Therapy Development
From Discovery to Preclinical Development: What are the critical stages to look out for? Introduction Chimeric Antigen Receptor (CAR) T cell therapy represents a transformative approach in medicine, particularly in oncology. This method offers personalised treatment...
Cell and Gene Therapy companies in Europe
European Cell & Gene Therapy CompaniesAt NecstGen, we aim to support industry partnerships and growth. And to enable the next generation of therapies, it is pivotal to have oversight of the gene and therapy landscape to start from, which is why we created this...
